Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Companion Sample Collection for Ribociclib in Breast Cancer
NCT03050398Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jun 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ribociclib in breast cancer, sponsored by Novartis. Started Jun 2017; status: terminated.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03050398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050398.